中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 10
Oct.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(10): 2384-2388

Value and clinical application of multiplex bead-based flow fluorescent immunoassay in the detection of autoantibodies in primary biliary cholangitis

DOI: 10.3969/j.issn.1001-5256.2021.10.025

  • Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China

Research funding:

Scientific Research Fund of The Affiliated Hospital of Qingdao University (20141201)

  • Received Date: 2021-02-23
  • Accepted Date: 2021-03-29
  • Published Date: 2021-10-20
    Abstract
  •   Objective  To investigate the value of multiplex bead-based flow fluorescent immunoassay (MBFFI) in the diagnosis of primary biliary cholangitis (PBC) by analyzing its results in detecting antimitochondrial antibody M2 subtype (AMA-M2), gp210 antibody, and sp100 antibody.  Methods  A total of 340 patients who attended The Affiliated Hospital of Qingdao University from August 2018 to June 2020 and were diagnosed with PBC were enrolled as PBC group, and 143 patients with other diseases and 117 individuals undergoing physical examination were also enrolled. MBFFI and immunoblotting test (IBT) were used to detect AMA-M2, gp210, and sp100 autoantibodies in serum, and the Kappa-test was used to compare the consistency of the two methods in detecting the same autoantibody; the receiver operating characteristic (ROC) curve was used to evaluate the value of MBFFI detection of three antibodies in the diagnosis of PBC; the chi-square test was used to compare positive.  Results  In the PBC group, the two methods showed the best consistency in detecting AMA-M2(Kappa=0.874) and showed relatively good consistency in detecting gp210 and sp100 antibodies (Kappa=0.713 and 0.749). MBFFI had the highest sensitivity of 72.06% in detecting AMA-M2; it had a sensitivity of 44.71% in the combined detection of gp210 and sp100 antibodies, which was higher than its sensitivity in detecting each antibody alone; it had a sensitivity of 82.65% in the combined detection of AMA-M2, gp210, and sp100 antibodies, which was higher than its sensitivity in detecting each antibody alone. Combined detection of the three antibodies had the largest area under the ROC curve of 0.907 0 in the diagnosis of PBC.  Conclusion  MBFFI has good consistency with IBT in detecting autoantibodies associated with PBC, and the combined detection of AMA-M2, gp210, and sp100 antibodies by MBFFI has higher sensitivity and value in the diagnosis of PBC.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    Chinese Society of Rheumatology. Guidelines for the diagnosis and treatment of autoimmune liver disease[J]. Chin J Rheumatol, 2011, 15(8): 556-558. DOI: 10.3760/cma.j.issn.1007-7480.2011.08.011.

    中华医学会风湿病学分会. 自身免疫性肝病诊断和治疗指南[J]. 中华风湿病学杂志, 2011, 15(8): 556-558. DOI: 10.3760/cma.j.issn.1007-7480.2011.08.011.
    [2]
    QIU DK, MA X. The diagnosis and management of autoimmune liver diseases[J]. Chin J Hepatol, 2005, 13(1): 66-67. DOI: 10.3760/j.issn:1007-3418.2005.01.016.

    邱德凯, 马雄. 自身免疫性肝病的诊断和治疗[J]. 中华肝脏病杂志, 2005, 13(1): 66-67. DOI: 10.3760/j.issn:1007-3418.2005.01.016.
    [3]
    HIRSCHFIELD GM, DYSON JK, ALEXANDER G, et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines[J]. Gut, 2018, 67(9): 1568-1594. DOI: 10.1136/gutjnl-2017-315259.
    [4]
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172. DOI: 10.1016/j.jhep.2017.03.022.
    [5]
    DANG FT, TANG YM. Diagnostic and prognostic value of autoantibodies in primary biliary cholangitis[J]. J Clin Hepatol, 2020, 36(5): 1164-1166. DOI: 10.3969/j.issn.1001-5256.2020.05.048.

    党富涛, 唐映梅. 自身抗体在原发性胆汁性胆管炎中的诊断及预后价值[J]. 临床肝胆病杂志, 2020, 36(5): 1164-1166. DOI: 10.3969/j.issn.1001-5256.2020.05.048.
    [6]
    RESHETNYAK VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis[J]. World J Gastroenterol, 2015, 21(25): 7683-7708. DOI: 10.3748/wjg.v21.i25.7683.
    [7]
    BRAUN S, BERG C, BUCK S, et al. Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis[J]. World J Gastroenterol, 2010, 16(8): 973-981. DOI: 10.3748/wjg.v16.i8.973
    [8]
    WANG CX, WANG JJ. Laboratory diagnosis of primary biliary cholangitis[J/CD]. Chin J Clin Lab Manage (Electronic Edition), 2017, 5(4): 197-199. DOI: 10.3877/cma.j.issn.2095-5820.2017.04.002.

    王春霞, 王佳佳. 原发性胆汁性胆管炎的实验室诊断[J/CD]. 中华临床实验室管理电子杂志, 2017, 5(4): 197-199. DOI: 10.3877/cma.j.issn.2095-5820.2017.04.002.
    [9]
    LIN H, LU ML, WANG Y. The current status of biomarkers in primary biliary cholangitis[J]. Labeled Immunoassays Clin Med, 2020, 27(7): 1261-1265. DOI: 10.11748/bjmy.issn.1006-1703.2020.07.036.

    林花, 路明亮, 王勇. 原发性胆汁性胆管炎的生物标志物研究进展[J]. 标记免疫分析与临床, 2020, 27(7): 1261-1265. DOI: 10.11748/bjmy.issn.1006-1703.2020.07.036.
    [10]
    SUN CY, MA X. An excerpt of EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis(2017)[J]. J Clin Hepatol, 2017, 33(10): 1888-1894. DOI: 10.3969/j.issn.1001-5256.2017.10.008.

    孙春燕, 马雄. 《2017年欧洲肝病学会临床实践指南: 原发性胆汁性胆管炎的诊断和管理》摘译[J]. 临床肝胆病杂志, 2017, 33(10): 1888-1894. DOI: 10.3969/j.issn.1001-5256.2017.10.008.
    [11]
    PEREZ D, GILBURD B, AZOULAY D, et al. Antinuclear antibodies: Is the indirect immunofluorescence still the gold standard or should be replaced by solid phase assays?[J]. Autoimmun Rev, 2018, 17(6): 548-552. DOI: 10.1016/j.autrev.2017.12.008.
    [12]
    NIU GH, GAO YJ, ZHANG C, et al. Establishment and clinical application of multiplex flow cytometric immuno-bead array assay technology in detecting primary Sjogren's syndrome[J]. Lab Med Clin, 2016, 13(14): 1911-1913. DOI: 10.3969/j.issn.1672-9455.2016.14.003.

    牛广华, 高玉洁, 张程, 等. 流式免疫多重微球芯片技术检测干燥综合征自身抗体的评价及应用[J]. 检验医学与临床, 2016, 13(14): 1911-1913. DOI: 10.3969/j.issn.1672-9455.2016.14.003.
    [13]
    CUI NN, WANG QX, MA X. An excerpt of diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases[J]. J Clin Hepatol, 2020, 36(4): 758-763. DOI: 10.3969/j.issn.1001-5256.2020.04.009.

    崔娜娜, 王绮夏, 马雄. 《2019年美国肝病学会实践指引和指南: 成人和儿童自身免疫性肝炎的诊断与治疗》摘译[J]. 临床肝胆病杂志, 2020, 36(4): 758-763. DOI: 10.3969/j.issn.1001-5256.2020.04.009.
    [14]
    XIE CH, LI ZJ. Diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Gen Prac, 2020, 18(4): 527-528.

    谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528.
    [15]
    SHANG XY, YU T, SUN GR, et al. Evaluation and clinical application of a multiplex bead-based flow fluorescent immunoassay for detection of antinuclear antibody spectrum[J]. Chin J Immunol, 2019, 35(3): 331-334. DOI: 10.3969/j.issn.1000-484X.2019.03.016.

    尚晓莹, 于腾, 孙桂荣, 等. 多重微球流式荧光免疫技术检测抗核抗体谱的评价与临床应用[J]. 中国免疫学杂志, 2019, 35(3): 331-334. DOI: 10.3969/j.issn.1000-484X.2019.03.016.
    [16]
    de LISO F, MATINATO C, RONCHI M, et al. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: A review of literature[J]. Clin Chem Med, 2017, 56(1): 25-31. DOI: 10.1515/cclm-2017-0249.
    [17]
    XIAO JG, PAN XY. Detection of autoantibodies in autoimmune liver disease[J/CD]. Clin Lab J (Electronic Edition), 2018, 7(2): 366.

    肖金根, 潘细牙. 自身免疫性肝病的自身抗体检测技术探讨[J/CD]. 临床检验杂志(电子版), 2018, 7(2): 366.
    [18]
    PENG L, WANG KZ. Research progress in clinical application and experimental diagnosis of autoantibodies[J]. Int J Lab Med, 2015, 36(10): 1425-1428. DOI: 10.3969/j.issn.1673-4130.2015.10.047.

    彭玲, 王开正. 自身抗体临床应用及实验诊断研究进展[J]. 国际检验医学杂志, 2015, 36(10): 1425-1428. DOI: 10.3969/j.issn.1673-4130.2015.10.047.
    [19]
    VILLALTA D, SEAMAN A, TIONGSON M, et al. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis[J]. Clin Chem Lab Med, 2020, 58(9): 1499-1507. DOI: 10.1515/cclm-2020-0122.
    [20]
    ZHANG Q, LIU Z, WU S, et al. Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis[J]. Gastroenterol Res Pract, 2019, 2019: 8959103. DOI: 10.1155/2019/8959103.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (635) PDF downloads(39) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return